Summary
Signal counts
Assets tracked: 5
Watchlist assets: 5
Registry stop assets: 0
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Assets tracked: 5
Watchlist assets: 5
Registry stop assets: 0
https://clinicaltrials.gov/study/NCT01431196 | https://clinicaltrials.gov/study/NCT01006044 | https://clinicaltrials.gov/study/NCT01348256 | https://clinicaltrials.gov/study/NCT01734564 | https://clinicaltrials.gov/study/NCT03792724